Tobias S Iveland
Tobias S Iveland
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
2Cancer Clinic, St. Olav’s Hospital, Trondheim, Norway
1,2,
Lars Hagen
Lars Hagen
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
3Clinic of Laboratory Medicine, St. Olav’s Hospital, Trondheim, Norway
4Proteomics and Modomics Experimental Core, PROMEC, at NTNU and the Central Norway Regional Health Authority, Stjørdal, Norway
1,3,4,
Animesh Sharma
Animesh Sharma
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
3Clinic of Laboratory Medicine, St. Olav’s Hospital, Trondheim, Norway
4Proteomics and Modomics Experimental Core, PROMEC, at NTNU and the Central Norway Regional Health Authority, Stjørdal, Norway
1,3,4,
Mirta M L Sousa
Mirta M L Sousa
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
3Clinic of Laboratory Medicine, St. Olav’s Hospital, Trondheim, Norway
1,3,
Antonio Sarno
Antonio Sarno
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
3Clinic of Laboratory Medicine, St. Olav’s Hospital, Trondheim, Norway
1,3,
Kristian Lied Wollen
Kristian Lied Wollen
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
1,
Nina Beate Liabakk
Nina Beate Liabakk
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
3Clinic of Laboratory Medicine, St. Olav’s Hospital, Trondheim, Norway
1,3,
Geir Slupphaug
Geir Slupphaug
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
3Clinic of Laboratory Medicine, St. Olav’s Hospital, Trondheim, Norway
4Proteomics and Modomics Experimental Core, PROMEC, at NTNU and the Central Norway Regional Health Authority, Stjørdal, Norway
1,3,4,✉
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health, Norwegian University of Science and Technology, 7491 Trondheim, Norway
2Cancer Clinic, St. Olav’s Hospital, Trondheim, Norway
3Clinic of Laboratory Medicine, St. Olav’s Hospital, Trondheim, Norway
4Proteomics and Modomics Experimental Core, PROMEC, at NTNU and the Central Norway Regional Health Authority, Stjørdal, Norway
© The Author(s) 2021
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
